glp 1 release Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Schematic illustration of GLP-1 release

Contraindication screening : Tirzepatide is contraindicated in personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and in patients with severe hypersensitivity to tirzepatide

To find out more about the formulation, how biotic solutions are becoming the cornerstone of the weight management scene and the molecular mechanisms underlying the nutraceuticals efficacy, NBR caught up with resbiotics founder and CEO, Dr Vivek Lal

The effect of semaglutide on mitochondrial function and insulin sensitivity in a myotube model of insulin resistance

Total cerebral blood flow in relation to cognitive function: The Rotterdam Scan Study